With the promise of legalization, psychedelic companies are jousting over future profits

Cash-rich start-ups file dozens of patent applications for hallucinogens like magic mushrooms. Researchers and patient advocates worry that high prices will make therapies unaffordable.


Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it through programmatic technology on the site and not from a human editor.
Back to top button